FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The FUS protein is implicated in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
• Understanding FUS's role in RNA metabolism is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To investigate how FUS regulates gene expression and RNA splicing across different central nervous system cell types.
• To identify FUS-regulated genes and pathways relevant to ALS and FTLD.

Main Methods:

• Comparative analysis of FUS-regulated transcriptome profiles in primary motor neurons, cortical neurons, cerebellar neurons, and glial cells.
• Examination of gene expression and alternative splicing events influenced by FUS.

Main Results:

• FUS-mediated gene expression and splicing patterns in motor neurons resembled those in cortical neurons, but differed from cerebellar neurons.
• Glial cells exhibited gene expression profiles similar to motor and cortical neurons.
• Key neurological disease-associated genes (e.g., Mapt, Stx1a, Scn8a) were identified among FUS-regulated targets.

Conclusions:

• Cell-type-specific transcriptome regulation by FUS influences cellular fate in ALS and FTLD.
• Identified RNA targets of FUS represent potential therapeutic targets for ALS and FTD.